(Washington Post) – Investors say genetic prediction services for embryos, used by Elon Musk and others, are a trust fund for future children. Many scientists are skeptical.

Siddiqui is a rising starin the realm of fertility start-ups backed by tech investors. Her company, San Francisco-based Orchid Health, screens embryos for thousands of potential future illnesses, letting prospective parents plan their families with far more information about their progeny than ever before. For now, her approach has been taken up mostly in her moneyed social circle. But one day, maybe not far off, it could change the way many babies are made everywhere — posing new moral and political questions as reproduction could increasingly become an outcome not of sex but of genetic preselection and data-mining. (Read More)